...
首页> 外文期刊>Frontiers in Psychiatry >Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
【24h】

Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified

机译:警告的责任:抗抑郁黑匣子自杀警告是经验证明的

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The United States Food and Drug Administration issued a Black Box warning in October 2004 after placebo-controlled trials of antidepressant medications found an increased risk of suicidal thoughts and behaviors among children and adolescents taking antidepressant medications relative to placebo. Subsequently, some researchers have concluded that the Black Box warning caused severe unintended consequences; specifically, they have argued that the warning led to reduced use of antidepressants among youth, which led to more suicides. In this paper, we critically examine research regarding the Black Box warning’s alleged deleterious consequences. One study claimed that controlled trials did not actually find an increased risk of suicidality among youth taking fluoxetine relative to those taking placebo, but its measure of suicidality is likely invalid. We found that ecological time series studies claiming that decreasing antidepressant prescriptions are linked to higher rates of suicide attempts or actual suicides among youth were methodologically weak. These studies exhibited shortcomings including: selective use of time points, use of only a short-term time series, lack of performing statistical analysis, not examining level of severity/impairment among participants, inability to control confounding variables, and/or use of questionable measures of suicide attempts. Further, while some time-series studies claim that increased antidepressant prescriptions are related to fewer youth suicides, more recent data suggests that increasing antidepressant prescriptions are related to more youth suicide attempts and more completed suicides among American children and adolescents. We also note that case-control studies show increased risk of suicide attempts and suicide among youth taking antidepressants, even after controlling for some relevant confounds. As clinical trials have the greatest ability to control relevant confounds, it is important to remember such trials demonstrated increased risk of suicidality adverse events among youth taking antidepressants. The Black Box warning is firmly rooted in solid data whereas attempts to claim the warning has caused harm are based on quite weak evidence.
机译:美国食品药品监督管理局于2004年10月发布了一个黑匣子警告,抗抑郁药物的安慰剂对照试验发现儿童和青少年的自杀思想和行为的风险增加,相对于安慰剂,患有抗抑郁药物的儿童和青少年。随后,一些研究人员已经得出结论,黑匣子警告引起严重的意外后果;具体而言,他们认为警告导致青年之间的抗抑郁药减少,这导致更多的自杀。在本文中,我们批判性地研究了关于黑匣子警告所谓有害后果的研究。一项研究声称,受控试验实际上并未发现青年期间服用氟西汀的自由性的风险增加,但其自由性的衡量标准可能无效。我们发现,生态时间序列研究声称减少抗抑郁药处方与较高的自杀式速率或青年之间的实际自杀率相关联。这些研究表现出缺点,包括:选择性使用时间点,仅使用短期时间序列,缺乏表演统计分析,未检查参与者之间的严重程度/损伤水平,无法控制混淆变量,和/或使用可疑的自杀企图措施。此外,虽然一些时间序列研究声明增加的抗抑郁症处方与青少年的较少有关,但更新的数据表明,增加抗抑郁症处方与更多青年自杀企图有关,美国儿童和青少年之间的青年自杀企图和更新的自杀。我们还注意到,案例对照研究表明,即使在控制某些相关的混淆之后,青年患有抗抑郁药的青春期尝试和自杀的风险也会增加。由于临床试验具有最大的控制相关混淆能力,重要的是要记住此类试验表明,在服用抗抑郁药中的青年之间的破解不良事件的风险增加。黑匣子警告牢固地扎根于扎实的数据,而索赔警告的尝试造成伤害是基于相当薄弱的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号